Metabolic Syndrome Predisposes to Depressive Symptoms: A Population-Based 7-Year Follow-Up Study
The DOI matches its Crossref record.
Abstract
OBJECTIVE: Previous cross-sectional studies have suggested that patients with depression have a high risk for metabolic syndrome. As there is a paucity of data concerning the temporal relationship of depression and metabolic syndrome, we decided to evaluate the risk for developing depressive symptoms in patients with metabolic syndrome in a population-based follow-up study. METHOD: The prevalence of depressive symptoms and metabolic syndrome at baseline in 1998 and at 7-year follow-up in 2004/2005 was studied in a large, middle-aged, population-based sample collected from Central Finland. Depressive symptoms were measured with the Beck Depression Inventory, with a cutoff score of 10 points. Metabolic syndrome was assessed using the modified National Cholesterol Education Program Adult Treatment Panel III criteria. RESULTS: Nondepressed women and men with metabolic syndrome at baseline were twice as likely to have depressive symptoms at follow-up (OR = 2.2, 95% CI = 1.1 to 4.5 for women; OR = 2.2, 95% CI = 0.8 to 5.9 for men) as compared with the nondepressed cohort members without metabolic syndrome at baseline. CONCLUSIONS: The higher rate of depressive symptoms in the subgroup with metabolic syndrome suggests that the metabolic syndrome may be an important predisposing factor for the development of depression. Effective prevention and treatment of metabolic syndrome could also be important for the prevention of depression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Overweight, Obesity, and Depression: A Systematic Review and Meta-analysis of Longitudinal Studies
Luppino, F. S., de Wit, L. M., Bouvy, P. F., Stijnen, T., Cuijpers, P., Penninx, B. W. J. H., & Zitman, F. G. (2010) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.2 · Cited by 4,322
Penninx, B. W., Milaneschi, Y., Lamers, F., & Vogelzangs, N. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-129 · Cited by 839
Lambert, G. W., Straznicky, N. E., Lambert, E. A., Dixon, J. B., & Schlaich, M. P. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.02.002 · Cited by 347
Singh, M. (2014) · Frontiers in Psychology · doi:10.3389/fpsyg.2014.00925 · Cited by 337
Metabolic disturbances connecting obesity and depression
Hryhorczuk, C., Sharma, S., & Fulton, S. E. (2013) · Frontiers in Neuroscience · doi:10.3389/fnins.2013.00177 · Cited by 322
Mannan, M., Mamun, A., Doi, S., & Clavarino, A. (2016) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2015.12.008 · Cited by 280
Antidepressant-Induced Liver Injury: A Review for Clinicians
Voican, C. S., Corruble, E., Naveau, S., & Perlemuter, G. (2014) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13050709 · Cited by 275
Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.005 · Cited by 217
“, 2010), and some studies have shown that these conditions are associated with depression and other mood disorders (Koponen et al., 2008; Luppino et al., 2010).”
BackgroundZhao, G., Ford, E. S., Li, C., Tsai, J., Dhingra, S., & Balluz, L. S. (2011) · BMC Psychiatry · doi:10.1186/1471-244x-11-130 · Cited by 214
“The relationship between depression and waist circumference or abdominal obesity as a component of metabolic syndrome has been explored previously in studies examining the associations of metabolic syndrome with mental illness [39-43].”
BackgroundResultMetabolic syndrome and major depression
Marazziti, D., Rutigliano, G., Baroni, S., Landi, P., & Dell'Osso, L. (2014) · CNS Spectrums · doi:10.1017/s1092852913000667 · Cited by 210
“healthy non-depressed subjects.(23) It was concluded that the MeS may be an important predisposing factor for the development of depression, and consequently its effective prevention and treatment could also be important for the prevention of depression.”
BackgroundVan Reedt Dortland, A. K. B., Giltay, E. J., Van Veen, T., Zitman, F. G., & Penninx, B. W. J. H. (2010) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2010.01565.x · Cited by 191
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011) · Human Reproduction · doi:10.1093/humrep/der338 · Cited by 168
“The association of metabolic syndrome and depression has been reported in several studies of non-PCOS populations (Skilton et al., 2007; Koponen et al., 2008).”
BackgroundRethorst, C. D., Bernstein, I., & Trivedi, M. H. (2014) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09009 · Cited by 152
Diet, gut microbiota and cognition
Proctor, C., Thiennimitr, P., Chattipakorn, N., & Chattipakorn, S. C. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-016-9917-8 · Cited by 144
Giltay, E. J., Tishova, Y. A., Mskhalaya, G. J., Gooren, L. J. G., Saad, F., & Kalinchenko, S. Y. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01859.x · Cited by 140
Xu, Q., Anderson, D., & Lurie-Beck, J. (2011) · Obesity Research & Clinical Practice · doi:10.1016/j.orcp.2011.04.007 · Cited by 136
Hamer, M., Batty, G. D., & Kivimaki, M. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.30 · Cited by 132
Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap
McIntyre, R. S., Rasgon, N. L., Kemp, D. E., Nguyen, H. T., Law, C. W. Y., Taylor, V. H., Woldeyohannes, H. O., Alsuwaidan, M. T., Soczynska, J. K., Kim, B., et al. (2009) · Current Diabetes Reports · doi:10.1007/s11892-009-0010-0 · Cited by 127
“Koponen et al. [ 15 ] attempted to discern the temporal relationship between MeS and depression in men and women living in South Savo, Finland.”
BackgroundNousen, E. K., Franco, J. G., & Sullivan, E. L. (2013) · Neuroendocrinology · doi:10.1159/000355632 · Cited by 123
Kashani, L., Omidvar, T., Farazmand, B., Modabbernia, A., Ramzanzadeh, F., Tehraninejad, E. S., Ashrafi, M., Tabrizi, M., & Akhondzadeh, S. (2013) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2012.08.010 · Cited by 116
“Insulin resistance and impaired glucose tolerance is associated with higher frequency of depression (Koponen et al., 2008; Almeida et al., 2009).”
BackgroundKemp, D. E., Ismail-Beigi, F., Ganocy, S. J., Conroy, C., Gao, K., Obral, S., Fein, E., Findling, R. L., & Calabrese, J. R. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.06.033 · Cited by 109
“Not only can depression precipitate the occurrence of insulin resistance and states of increased cardiometabolic risk, but the metabolic syndrome (Koponen et al., 2008), type-2 diabetes (Pan et al., 2010), and abdominal obesity (Vogelzangs et al., 2010) have all been identified as risk factors for…”
BackgroundVogelzangs, N., Beekman, A. T. F., Boelhouwer, I. G., Bandinelli, S., Milaneschi, Y., Ferrucci, L., & Penninx, B. W. J. H. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06559 · Cited by 100
Beyazyüz, M., Albayrak, Y., Eğilmez, O. B., Albayrak, N., & Beyazyüz, E. (2013) · Psychiatry Investigation · doi:10.4306/pi.2013.10.2.148 · Cited by 83
Association of depressive symptoms and metabolic syndrome in men
Viinamäki, H., Heiskanen, T., Lehto, S. M., Niskanen, L., Koivumaa‐Honkanen, H., Tolmunen, T., Honkalampi, K., Saharinen, T., Haatainen, K., & Hintikka, J. (2009) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2008.01333.x · Cited by 68
“The second study, which examined both women and men, suggested that MetS may be a predisposing factor for depressive symptoms (15).”
BackgroundRole of metabolic dysfunction in treatment resistance of major depressive disorder
Toups, M. S., & Trivedi, M. H. (2011) · Neuropsychiatry · doi:10.2217/npy.11.49 · Cited by 9
Metadata
- Authors
- Koponen, H., Jokelainen, J., Keinänen-Kiukaanniemi, S., Kumpusalo, E., & Vanhala, M.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2008-02-15
- Volume
- 69
- Issue
- 2
- Pages
- 178-182
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2024174163
- Cited by
- 177
- References
- 0
- FWCI
- 15.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.